Submit justification: CDSCO Panel tells Hetero for FDC Lacosamide, Brivaracetam Dr. Divya Colin26 Feb 2023 6:00 PM ISTNew Delhi: In line with the drug maker Hetero Pharma's proposal for the fixed-dose combination Lacosamide plus Brivaracetam, the Subject Expert...
Eli Lilly Gets CDSCO Panel Nod To Import, Market Lasmiditan for acute treatment of migraine Dr. Divya Colin25 Feb 2023 6:00 PM ISTNew Delhi: Citing that the global clinical trial data demonstrate the efficacy and safety of Lasmiditan for the acute treatment of migraine with and...
Sun Pharma Gets CDSCO panel nod to manufacture, market antidiabetic FDC drug Dr. Divya Colin24 Feb 2023 6:00 PM ISTNew Delhi: In a significant development, pharmaceutical major, Sun Pharma has got the go-ahead from the Subject Expert Committee (SEC) functional...
Rajeev Singh Raghuvanshi takes charge as new Drugs Controller General of India Farhat Nasim23 Feb 2023 11:21 AM ISTNew Delhi: Rajeev Singh Raghuvanshi has been appointed as the new Drugs Controller General of India (DCGI), Central Drugs Standard Control...
CDSCO Drug Alert: 67 Drug Samples Including Sun Pharma Pantocid DSR, Alkem's Pan -D flagged Susmita Roy22 Feb 2023 5:47 PM ISTNew Delhi: In its latest drug safety alert, the apex drug regulatory body, Central Drugs Standard Control Organization (CDSCO) has flagged 67 medicine...
CDSCO panel seeks data for Eli Lilly's anticancer drug selpercatinib Dr. Divya Colin21 Feb 2023 6:00 PM ISTNew Delhi: In response to the drug major Eli Lilly's proposal to waive off Phase IV clinical trial in the country for the Selpercatinib 40 & 80mg...
Sun Pharma plea against NPPA price fixation for Acetazolamide IP 500 mg rejected Farhat Nasim20 Feb 2023 6:00 PM ISTNew Delhi: Upholding the retail price fixed by the National Pharmaceutical Pricing Authority (NPPA), the Department of Pharmaceuticals (DoP) has...
MSN Lab gets CDSCO Panel nod for phase III CT of Elagolix Tablets Dr. Divya Colin19 Feb 2023 6:00 PM ISTNew Delhi: The drug major MSN Laboratories has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Mylan gets CDSCO panel nod to manufacture, market Pretomanid for drug resistant TB Dr. Divya Colin18 Feb 2023 6:00 PM ISTNew Delhi: Mylan Laboratories has got a go ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Zydus Healthcare gets CDSCO panel nod to study Dydrogesterone film coated Sustained Release Tablets Dr. Divya Colin17 Feb 2023 6:00 PM ISTNew Delhi: Suggesting to monitor the size of endometrioma during the study, the Subject Expert Committee (SEC) functional under the Central Drug...
HC relief to Abbott India, allows Rs 48 crore spent on gifts to doctors in 2008-09 to be claimed as expense Farhat Nasim16 Feb 2023 7:21 PM ISTMumbai: In respite to drug maker Abbott India Ltd., the Bombay High Court has ruled that the CBDT Circular issued in 2012 as per which the expenses...
Lack of Strong Evidence: CDSCO panel rejects Glenmark proposal of using Nitric Oxide Nasal Spray for COVID-19 prevention Dr. Divya Colin15 Feb 2023 6:00 PM ISTNew Delhi: Citing lack of strong evidence on the use of Nitric Oxide Nasal Spray for prevention of COVID-19 infection, the Subject Expert Committee...
